Belatacept Pharmacokinetic Trial in Renal Transplantation
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics and safety of belatacept in de
novo renal transplant subjects treated with belatacept-based immunosuppressant medication